BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28440547)

  • 1. Development of LC-QTOF-MS method for human lung tissue fingerprinting. A preliminary application to nonsmall cell lung cancer.
    Ciborowski M; Kisluk J; Pietrowska K; Samczuk P; Parfieniuk E; Kowalczyk T; Kozlowski M; Kretowski A; Niklinski J
    Electrophoresis; 2017 Sep; 38(18):2304-2312. PubMed ID: 28440547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis.
    Inoue K; Tsuchiya H; Takayama T; Akatsu H; Hashizume Y; Yamamoto T; Matsukawa N; Toyo'oka T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():24-34. PubMed ID: 25463194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the technical variations and the suitability of a hydrophilic interaction liquid chromatography-high resolution mass spectrometry (ZIC-pHILIC-Exactive orbitrap) for clinical urinary metabolomics study.
    Zhang T; Watson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():199-205. PubMed ID: 27107246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exploratory approach for an oriented development of an untargeted hydrophilic interaction liquid chromatography-mass spectrometry platform for polar metabolites in biological matrices.
    Iturrospe E; Da Silva KM; Talavera Andújar B; Cuykx M; Boeckmans J; Vanhaecke T; Covaci A; van Nuijs ALN
    J Chromatogr A; 2021 Jan; 1637():461807. PubMed ID: 33360078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
    Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
    Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplatform analytical methodology for metabolic fingerprinting of lung tissue.
    Naz S; García A; Barbas C
    Anal Chem; 2013 Nov; 85(22):10941-8. PubMed ID: 24144172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures.
    Wei Y; Tong J; Taylor P; Strumpf D; Ignatchenko V; Pham NA; Yanagawa N; Liu G; Jurisica I; Shepherd FA; Tsao MS; Kislinger T; Moran MF
    J Proteome Res; 2011 Jan; 10(1):161-74. PubMed ID: 20815376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Small Cell Lung Cancer Detection and Subtyping by UPLC-HRMS-Based Tissue Metabolomics.
    Zang X; Zhang J; Jiao P; Xue X; Lv Z
    J Proteome Res; 2022 Aug; 21(8):2011-2022. PubMed ID: 35856400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance comparison of narrow-bore and capillary liquid-chromatography for non-targeted metabolomics profiling by HILIC-QTOF-MS.
    Neef SK; Hofmann U; Mürdter TE; Schwab M; Haag M
    Talanta; 2023 Aug; 260():124578. PubMed ID: 37119797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Metabolomic and Lipidomic Profiling of Human Kidney Tissue: A Platform Comparison.
    Leuthold P; Schaeffeler E; Winter S; Büttner F; Hofmann U; Mürdter TE; Rausch S; Sonntag D; Wahrheit J; Fend F; Hennenlotter J; Bedke J; Schwab M; Haag M
    J Proteome Res; 2017 Feb; 16(2):933-944. PubMed ID: 27992229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of early stage non-small-cell lung cancer using Orbitrap-based global serum metabolomics.
    Klupczynska A; Dereziński P; Garrett TJ; Rubio VY; Dyszkiewicz W; Kasprzyk M; Kokot ZJ
    J Cancer Res Clin Oncol; 2017 Apr; 143(4):649-659. PubMed ID: 28168355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtyping non-small cell lung cancer by histology-guided spatial metabolomics.
    Neumann JM; Freitag H; Hartmann JS; Niehaus K; Galanis M; Griesshammer M; Kellner U; Bednarz H
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):351-360. PubMed ID: 34839410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of LC-MS-based metabolomics method in differentiating septic survivors from non-survivors.
    Liu Z; Yin P; Amathieu R; Savarin P; Xu G
    Anal Bioanal Chem; 2016 Nov; 408(27):7641-7649. PubMed ID: 27614981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
    Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
    Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and identification of potential biomarkers of non-small cell lung cancer.
    Yang Y; Zhao S; Fan Y; Zhao F; Liu Q; Hu W; Liu D; Fan K; Wang J; Wang J
    Technol Cancer Res Treat; 2009 Dec; 8(6):455-66. PubMed ID: 19925029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
    Peng J; Chen YT; Chen CL; Li L
    Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annotation of the human serum metabolome by coupling three liquid chromatography methods to high-resolution mass spectrometry.
    Boudah S; Olivier MF; Aros-Calt S; Oliveira L; Fenaille F; Tabet JC; Junot C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():34-47. PubMed ID: 24815365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precise pathological classification of non-small cell lung adenocarcinoma and squamous carcinoma based on an integrated platform of targeted metabolome and lipidome.
    Cao P; Wu S; Guo W; Zhang Q; Gong W; Li Q; Zhang R; Dong X; Xu S; Liu Y; Shi S; Huang Y; Zhang Y
    Metabolomics; 2021 Nov; 17(11):98. PubMed ID: 34729658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fingerprinting-based metabolomic approach with LC-MS to sleep apnea and hypopnea syndrome: a pilot study.
    Ferrarini A; Rupérez FJ; Erazo M; Martínez MP; Villar-Álvarez F; Peces-Barba G; González-Mangado N; Troncoso MF; Ruiz-Cabello J; Barbas C
    Electrophoresis; 2013 Oct; 34(19):2873-81. PubMed ID: 23775633
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.